NCT07263906
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- The Second Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Recurrent Acute Myeloid Leukemia
Explore clinical trials studying Recurrent Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
81 public trials
32 recruiting studies
Recurrent Acute Myeloid Leukemia trial results
NCT04905810
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- UCSF-Fresno Clovis, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
Not yet recruiting
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
NCT07583303
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
NCT05035706
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
NCT02530034
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
- Locations
-
- Augusta University Augusta, Georgia, United States
- Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
Active, not recruiting
TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts
NCT03816319
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States
Active, not recruiting
Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
NCT03953898
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Post Cytotoxic Therapy, +13 more
- Locations
-
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Yale University New Haven, Connecticut, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
Active, not recruiting
Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT02890329
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
Active, not recruiting
Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
NCT04746235
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia
NCT04158739
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States